Risks
4 risks
Risk Intelligence
Geopolitical uncertainty from Middle East war
View Risks →
Sharda Cropchem Ltd — Q4 FY26
Sharda Cropchem delivered a stellar Q4 FY26, with revenue growing 13% YoY to ₹2,065 crore, EBITDA surging 75% to ₹513 crore (margin 24.8%, up 750bps), and PAT rising 57% to ₹319 crore.
bullish
high
✓ Verified against BSE filing
2-Minute Summary
✦ AI-Generated from Full Transcript
Sharda Cropchem delivered a stellar Q4 FY26, with revenue growing 13% YoY to ₹2,065 crore, EBITDA surging 75% to ₹513 crore (margin 24.8%, up 750bps), and PAT rising 57% to ₹319 crore. The full year saw revenue of ₹5,268 crore (+22% YoY) and PAT of ₹681 crore (+124% YoY). Growth was driven by volume expansion (+4.3% in Q4, +13.4% full year) and favorable forex (+11.7% in Q4), partially offset by negative price/mix (-3.0%). Gross margins expanded 750bps to 37.3% due to better product mix and pricing discipline. Management guided FY27 revenue growth of 10-15%, gross margins around 35%, and EBITDA margins of 18-20%. Key risks include geopolitical uncertainty from the Middle East war and potential raw material price increases, though management believes 80-90% of cost increases can be passed on due to limited competition from registration barriers.
Risks4 trackedTranscriptfull text
Research workspace
Focused Modules
Transcript
Full text
Call Transcript
Full transcript text is available on this route.
Read Transcript →Quarter Snapshot
Total Product Registrations
3,111
+161 YoY
As on 31st March 2026, total product registrations stood at 3,111, with 1,104 applications in pipeline.
Volume Growth (Q4)
4.3%
+4.3pp YoY
Volume growth for Q4 FY26 was 4.3% year-on-year, driven by Europe and Latam.
Working Capital Days
98 days
-20 days YoY
Working capital days improved to 98 days as on 31st March 2026 from 118 days a year ago.
Cash & Liquid Investments
₹702 crore
N/A
Company remains debt-free with cash and liquid investments of ₹702 crore as on 31st March 2026.
Fast read
Guidance and risk preview
Management expects revenue to grow by 10-15% in FY27, driven by volume growth of around 15% and stable pricing.
The ongoing war in the Middle East creates uncertainty in supply chains and raw material availability, though no major impact seen yet.
View Risks →